» Articles » PMID: 28785871

Specialized Survivor Clinic Attendance Increases Adherence to Cardiomyopathy Screening Guidelines in Adult Survivors of Childhood Cancer

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2017 Aug 9
PMID 28785871
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine if attendance at a specialized clinic for adult survivors of childhood cancer is associated with better rates of adherence to the Children's Oncology Group (COG) Long-term Follow-up (LTFU) guidelines for cardiomyopathy screening.

Methods: We conducted a retrospective population-based study using administrative data in Ontario, Canada of 5-year survivors diagnosed between 1986 and 2005 at risk of therapy-related late cardiomyopathy. Patients were classified into three groups based on the recommended frequency of screening: annual, every 2 years, and every 5 years.

Results: Of 1811 eligible survivors followed for median 7.8 years (range 0-14.0), patients were adherent to screening for only 8.6% of their period of follow-up. Survivor clinic utilization had the strongest association with increased rates of adherence: when compared to no attendance, ≥ 5 clinic visits/10-year period had RR of adherence of 10.6 (95% CI 5.7-19.5) in the annual group, 3.3 (95% CI 2.3-4.8) in the every 2-year group, and 2.3 (95% CI 1.6-3.2) in the every 5-year group. Additional factors associated with increased adherence after adjusting for clinic attendance included annual assessment by a general practioner, female sex, diagnosis prior to 2003, and living in a rural area.

Conclusions: In a model of specialized survivor care, increased clinic utilization is associated with improved patient adherence to COG LTFU cardiomyopathy screening guidelines.

Implications For Cancer Survivors: Specialized survivor clinics may improve health outcomes in survivors through improved adherence to screening. However, rates of adherence remain suboptimal and further multifacetted strategies need to be explored to improve overall rates of screening in adult survivors of childhood cancer.

Citing Articles

The decision to disclose to your child they are a childhood cancer survivor: a qualitative study of barriers and facilitators using the theoretical domain framework.

Shuldiner J, Lord B, Rinaldo E, Shah N, Nguyen P, Lam E J Cancer Surviv. 2024; .

PMID: 39673027 DOI: 10.1007/s11764-024-01725-w.


Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities.

Berkman A, Betts A, Beauchemin M, Parsons S, Freyer D, Roth M J Natl Cancer Inst. 2024; 116(9):1417-1428.

PMID: 38833671 PMC: 11378318. DOI: 10.1093/jnci/djae119.


Utilization of cardiac tests in anthracycline-treated cancer survivors differs between young adults and children: A claims-based analysis.

Ji X, Hu X, Lipscomb J, Chow E, Mertens A, Castellino S Cancer Med. 2023; 12(24):22056-22061.

PMID: 38070180 PMC: 10757126. DOI: 10.1002/cam4.6801.


Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?.

Bougas N, Allodji R, Fayech C, Haddy N, Mansouri I, Journy N Br J Cancer. 2023; 129(8):1298-1305.

PMID: 37604931 PMC: 10575933. DOI: 10.1038/s41416-023-02400-0.


Disparities in pediatric cancer survivorship care: A systematic review.

Mobley E, Moke D, Milam J, Ochoa-Dominguez C, Stal J, Mitchell H Cancer Med. 2023; 12(17):18281-18305.

PMID: 37551113 PMC: 10524017. DOI: 10.1002/cam4.6426.


References
1.
Phillips S, Padgett L, Leisenring W, Stratton K, Bishop K, Krull K . Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev. 2015; 24(4):653-63. PMC: 4418452. DOI: 10.1158/1055-9965.EPI-14-1418. View

2.
Ristovski-Slijepcevic S, Barr R, Bernstein M, Nathan P . A cross-Canada survey of clinical programs for the care of survivors of cancer in childhood and adolescence. Paediatr Child Health. 2010; 14(6):375-8. PMC: 2735378. View

3.
Hudson M, Leisenring W, Stratton K, Tinner N, Steen B, Ogg S . Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol. 2014; 32(35):3974-81. PMC: 4251960. DOI: 10.1200/JCO.2014.57.3493. View

4.
Nathan P, Greenberg M, Ness K, Hudson M, Mertens A, Mahoney M . Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008; 26(27):4401-9. PMC: 2653112. DOI: 10.1200/JCO.2008.16.9607. View

5.
Lipshultz S, Lipsitz S, Sallan S, Simbre 2nd V, Shaikh S, Mone S . Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002; 20(23):4517-22. DOI: 10.1200/JCO.2002.12.102. View